This inventor holds 2 USPTO granted patents. Top assignee: Alexion Pharmaceuticals, Inc.. Active years: 2020-2022.
Company Filing History:
Years Active: 2020-2022
Title: Nina Jain: Innovator in Genetic Research
Introduction
Nina Jain is a prominent inventor based in North Andover, MA (US). She has made significant contributions to the field of genetic research, particularly in the study of lysosomal acid lipase deficiency and N-acetyl-alpha-D-glucosaminidase deficiency. With a total of 2 patents, her work has the potential to impact the understanding and treatment of genetic disorders.
Latest Patents
Nina Jain's latest patents include compositions and methods for lysosomal acid lipase deficiency. This patent focuses on potentially pathogenic mutations in the nucleotide sequence of the human LIPA gene. Some LIPA gene products have been discovered to be associated with reduced lysosomal acid lipase (LAL) activity. Additionally, she has developed compositions and methods relating to N-acetyl-alpha-D-glucosaminidase deficiency. This patent addresses potentially pathogenic mutations in the nucleotide sequence of the human NAGLU gene, with some variants linked to reduced N-acetyl-alpha-D-glucosaminidase (NAGLU) activity.
Career Highlights
Nina Jain is currently employed at Alexion Pharmaceuticals, Inc., where she continues her research and development efforts. Her work is crucial in advancing the understanding of genetic conditions and their treatments.
Collaborations
Nina collaborates with notable colleagues, including Andrew Hutchinson and Christen D Forbes. Their combined expertise enhances the research initiatives at Alexion Pharmaceuticals.
Conclusion
Nina Jain's innovative work in genetic research exemplifies the impact of dedicated inventors in the field of medicine. Her contributions are paving the way for advancements in the treatment of genetic disorders.